The Valley Desk

Clinical trial reportPloS onePublished

Iodine increases pulmonary type I interferon responses and decreases covid-19 disease severity: Results from an open label randomized clinical trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
PloS one
Published
Subject terms
Lung; Humans; Iodine; Interferon Type I; Hospitalization; Severity of Illness Index; Aged; Middle Aged; Intensive Care Units; Female; Male; COVID-19
PubMed ID
41628126
PubMed Central ID
PMC12863515
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal